Requirement 1: a method for treating cancer patients, which includes providing patients with an effective number of treatments, from antagonists to VEGF, In both cases, the level of CD31 and / or VEGFA was higher than the average level of carcinogenesis and / or VEGFA respectively. Claim 12: Method in accordance with any claims 1 to 11,It is characterized by the fact that veff's antiviral drugs are used in combination with one or more additional chemotherapy agents in one chemotherapy method. 13. Claim 13: a method conforming to claim 12, characterized in that one or more additional chemotherapy agents are selected from the group, including: chemotherapy agents, her antibodies, targeted antibodies, tumor related antigens, anti hormone compounds, heart protectors, Citoquina, a drug for EGFR, antiangiogenic agent, thyroid hormone quinase, inhibitor, COX inhibitor, nonsteroidal anti-inflammatory drug, referral inhibitor,Antibody binding to tumor protein CA125, HER2 vaccine, targeting therapy, RAF or Ras inhibitor, libodo krubisin, tobotkin, taxano, antithyroid quina inhibitor, tlk286, emd-7200, a drug for nausea, A drug that prevents or treats rashes or standard acne, a drug that treats or prevents diarrhea, a drug that lowers body temperature, and a blood growth factor. Claim 21: Method in accordance with any claims 1 to 20,The opponent described as VEGF is an anti VEGF antibody Claim 22: Method in accordance with claim 21, characterized by an ant vegg antibody of bevazzoub.Reivindicación 1: Un método para tratar a un paciente con un cáncer, el método incluye administrar al paciente una cantidad terapéuticamente efectiva, de un antagonista, de VEGF, en donde el cáncer del paciente se ha determinado que expresa CD31 y/o VEGFA tumoral en un nivel mayor que el nivel medio para la expresión de CD31 y/o VEGFA tumoral, respectivamente, en el tipo de cáncer. Reivindicación 12: El método de conformidad con cualquiera de las reivindicaciones 1 a 11, caracterizado porque el ant
